ZSAN Zosano Pharma Corp

Zosano Pharma Corp is a clinical-stage specialty pharmaceutical company. It has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of various indications.

$0.92
As of 06/21/2021     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/27/2015
Outstanding shares:  106,728,371
Average volume:  3,567,117
Market cap:   $104,593,804
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    98979H202
ISIN:        US98979H2022
Sedol:      BD95YC6

---

Valuation   (See tab for details)

---

PE ratio:   -6.07
PB ratio:   2.28
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%